(1.9%) serum samples from blood donors (P < 0.01 for either of the at-risk groups versus blood donors). The results of this study suggest that the HGE agent or a closely related organism exists in southern Germany and that seroconversion to it is common among groups exposed to Ixodes ticks. Final proof that HGE occurs in Germany will require the isolation of the causative agent from patients. HGE should be considered in the differential diagnosis of febrile illnesses in individuals exposed to Ixodes ticks in Europe as well as in North America.
Ehrlichiae are obligate intracellular bacteria that infect leukocytes or platelets of various mammalian species (26) . Human granulocytic ehrlichiosis (HGE) is a newly described, sometimes fatal febrile syndrome (3, 10) . The causative agent is closely related to animal pathogens in the Ehrlichia phagocytophila group (1, 6, 7) , and it is transmitted by the bite of infected ticks in the I. ricinus-I. persulcatus complex (14) , e.g., Ixodes scapularis and Ixodes pacificus (10, 13, 16, 23, 25, 29) . These ticks are also the vector for Lyme borreliae in the United States, and in Europe, I. ricinus and I. persulcatus have been shown to transmit Borrelia burgdorferi (2, 5) , and coinfection with B. burgdorferi and granulocytotropic ehrlichiae was recently documented (16) .
The diagnosis of HGE is difficult because of its nonspecific symptoms, most commonly fever, malaise, headache, myalgia, and arthralgia. The diagnosis is usually based on the clinical presentation in combination with a history of exposure to Ixodes ticks. Laboratory findings suggestive of the disease include leukopenia, thrombocytopenia, anemia, and elevated serum transaminases (3, 4, 13) . Microbiologic diagnosis in the acute phase of the disease has relied on Giemsa-stained blood smears with demonstration of intragranulocytic ehrlichial inclusions (morulae), which are, however, often rare. Antibody detection with antigens from the closely related Ehrlichia equi is insensitive at the time of clinical presentation, and it is usually necessary to obtain convalescent-phase titers to confirm the diagnosis (4). Amplification of 16S rDNA sequences by PCR with oligonucleotide primers specific for the human granulocytotropic ehrlichiae provides a more sensitive diagnostic method (13, 22) . In addition, the pathogen can now be isolated in cell culture (13) . Thus far, human infection with a granulocytic Ehrlichia species outside the United States has been shown only in one case from Slovenia by serology and PCR detection (24) . Serological surveys using the closely related E. phagocytophila or E. equi as antigens suggest that HGE might exist in Europe (8, 28) .
The purpose of the present study was to determine the prevalence of antibodies against the HGE agent in southern Germany by utilizing an immunofluorescence assay which uses a human patient isolate grown in vitro as the source of antigen (13) . If HGE exists in Europe, it seems very likely that it would be transmitted by ticks of the I. ricinus-I. persulcatus complex. Therefore, we studied sera from forestry workers and patients with Lyme borreliosis as tick-exposed populations potentially at high risk for infection. Sera from healthy blood donors without a history of known tick bites served as controls. Compared with the blood donors, the prevalence of HGE antibody titers was significantly higher in both risk groups, suggesting that HGE is a tick-borne infection which also occurs in southern Germany.
MATERIALS AND METHODS

Serum samples. (i) Forestry workers.
One hundred fifty serum samples from forestry workers were collected in the years 1983 and 1984 from seven different forest management areas in southern Germany (19) . The forestry workers were asked to fill out a questionnaire providing information about age, number of tick bites in the last 5 years, the last tick bite they could remember, and current or previous clinical symptoms, such as fever, joint manifestations, skin rashes, and neurologic symptoms.
(ii) Patients with Lyme borreliosis. Serum samples from 105 patients from southern Germany with clinically and serologically defined Lyme borreliosis (41 with erythema migrans, 38 with Bannwarth's syndrome, 12 with acrodermatitis chronica atrophicans, and 14 with Lyme arthritis) were collected from 1988 to 1996. The diagnosis was made by experienced physicians familiar with the manifestations of Lyme borreliosis.
(iii) Control group. The control group consisted of 103 serum samples from healthy persons living in southern Germany without a history of known tick bites or of rheumatologic, dermatologic, or neurologic diseases. Furthermore, 53 serum samples from patients with conditions other than HGE (Table 1) were tested as problem sera in HGE IFA.
IFA for anti-HGE antibody detection. HGE-infected HL60 cells (13) were harvested by centrifugation at 500 ϫ g for 10 min. Cell pellets were resuspended in their growth medium to a final concentration of 2 ϫ 10 7 cells/ml, and 8-l aliquots of the suspension were placed into the wells of Teflon-coated 18-well slides (Cel-Line Associates, Newfield, N.J.). After air drying, slides were fixed for 10 min by immersion in a mixture of 50% methanol and 50% acetone. For screening, sera were diluted 1:80 in phosphate-buffered saline (pH 7.2) (PBS). After incubation for 1 h in a humid chamber at room temperature, the slides were rinsed with two changes of PBS and washed for 5 min in PBS. The slides were then incubated with fluorescein isothiocyanate-conjugated goat anti-human immunoglobulin G (IgG) or IgM (Cappell) at dilutions of 1:240 for IgG and 1:40 for IgM. Slides were again incubated for 1 h in a moist chamber at room temperature and then rinsed twice with PBS and counterstained for 5 min in PBS with 0.005% Evans blue. Sera reactive at 1:80 were serially diluted to determine actual antibody titers. Titers of Ն1:80 were considered positive, because negative control sera from healthy subjects are not reactive with the HGE agent at this dilution (13a). Serum from a healthy laboratory worker without a history of a tick bite or of rheumatological, dermatological, or neurological disease served as the negative control. The positive control serum was obtained from a patient from Wisconsin with proven Lyme borreliosis who also tested positive in HGE IFA with a titer of 1:320 for both IgG and IgM.
B. burgdorferi ELISA. For detection of antibodies against B. burgdorferi, the Enzygnost Borreliosis enzyme-linked immunosorbent assay (ELISA) test kit for IgG and IgM was used as recommended by the manufacturer (Behringwerke AG, Marburg, Germany). For IgG, a test result of Ն10 U/ml was regarded as positive, and for IgM, a test result of Ͼ0.352 (optical density) was regarded as positive (30) . All sera were tested for IgG, and in addition, IgM antibody titers were determined in sera from patients with Lyme borreliosis and healthy blood donors.
Statistics. For statistical analysis, Fisher's exact test for dichotomous variables was performed.
RESULTS
Forestry workers. Antibody titers of Ն1:80 against HGE were found in 21 (14.0%) of the 150 serum samples from forestry workers (Table 2 ). Eighteen (12%; range of titers, 1:80 to 1:2,560) samples had only IgG antibodies, 2 (1.3%; titer of 1:80 in each) had only IgM, and 1 (0.7%) had both IgG (1:10,240) and IgM (1:1,280) antibodies. Ninety-five percent of the HGE-seropositive forestry workers remembered tick bites during the last 5 years, and 65% of them reported more than 10 tick bites. A similar number of tick bites was reported by the seronegative forestry workers. Clinical symptoms remembered from the last 5 years were reported by 7 (33.3%) of the seropositive and 41 (31.8%) of the seronegative forestry workers. In detail, comparing seropositive versus seronegative forestry workers, respectively, erythema was reported by 2 (9.5%) and 10 (7.8%) workers, arthralgia or arthritis was reported by 4 (19.4%) and 28 (21.7%) workers, combined erythema and arthralgia were reported by 1 (4.8%) and 3 (2.3%) workers, and accompanying fever was reported by 0 and 5 (3.9%) workers. Twelve (57.1%) of 21 HGE-positive serum samples also contained IgG antibodies to Lyme borreliae, compared to 68 (52.7%) of the HGE-negative sera. Antibody prevalence to the HGE agent varied between 5.9 and 20% in the seven forest management areas (Table 3) , and there was no correlation with the presence of antibody to B. burgdorferi.
Patients with Lyme borreliosis. HGE antibody titers of Ն1:80 were found in 12 (11.4%) of 105 patients with Lyme borreliosis (Table 2 and 4). Positive IgG titers without IgM were detected in seven serum samples (range, 1:80 to 1:640), three serum samples contained only IgM antibodies (titers from 1:80 to 1:160), and in two serum samples, both IgG (1:80 and 1:320) and IgM (1:320 in both) antibodies were present. Eleven of the 12 HGE-seropositive patients recalled tick bites.
Control group. Anti-HGE IgG antibodies were detected in 2 (1.9%) of the 103 serum samples from the healthy control group (titers of 1:80 and 1:320); IgM antibodies were not found ( Table 2 ). One serum sample tested positive for IgG antibodies to B. burgdorferi, and three were positive for anti-B. burgdorferi IgM. No control sera were positive for both B. burgdorferi and HGE antibodies. Sera from patients with conditions other than HGE (Table  1) showed anti-HGE antibody titers Ն1:80 in three (5.7%) cases. One serum sample (1.9%) from a patient with chronic fatigue syndrome showed elevated IgG antibodies (titer 1:320), and two serum samples (3.8%), both from patients with Rocky mountain spotted fever, had only elevated IgM levels (titers of 1:320 each). Taking all control sera together, the specificity of the HGE IFA results in 98.7% for IgM and 98.1% for IgG IFA.
DISCUSSION
HGE is an acute, febrile illness which can be life threatening, and the common clinical and laboratory findings are nonspecific. Because of the potential severity of the illness and the efficacy of appropriate antibiotic treatment, accurate diagnosis is important. Since detection of HGE antibodies with E. equi as an antigen is problematic (4, 21), improved serologic methods are needed to better define the epidemiology of this emerging infection. Recently, Nicholson et al. (21) showed that use of HGE-infected HL60 cells improves serological testing. We have exploited the recent isolation of the etiologic agent (13) to develop a reproducible and specific IFA utilizing the cultured pathogen as the source of antigen. We found a significantly higher prevalence of HGE antibodies among patients with Lyme borreliosis (P Յ 0.01) and forestry workers (P Յ 0.01) than that in blood donors, suggesting that infection with HGE or a closely related agent occurs in southern Germany. Sera from individual forestry workers who reported having experienced clinical symptoms compatible with HGE were no more likely to test positive by IFA than those who did not recall such symptoms. A similar situation has been noted in individuals who were tested for antibodies to B. burgdorferi (19) and may reflect the poorly defined clinical picture that is typical for each of these diseases. Furthermore, cross-reactivity by non-Ehrlichia species antibodies may account for some reactivity in these sera. One serum sample with exceptionally high titers for IgG (1:10,240) and IgM (1:1,280), suggestive of a recent infection, came from a 50-year-old forestry worker who recalled numerous tick bites but no clinical symptoms attributable to HGE. Asymptomatic infections with this or closely related pathogens (e.g., E. equi or E. phagocytophila, both known to occur in Europe [9, 12, 26, 27] ) may account for this result. E. equi and E. phagocytophila are very similar antigenically (11), but whether E. equi and E. phagocytophila, if they are species distinct from the HGE agent, can cause human disease has not been established.
It has been suggested that active HGE may cause falsepositive Lyme disease serology results when ELISA and immunoblotting are used (31) . Our study, based on a larger number of serum samples and comparing defined high-and low-risk groups, did not identify any correlation between serum antibody titers to HGE and to Lyme disease (data not shown). As also found in the present study, Magnarelli et al. (17) and Mitchell et al. (18) described the presence of antibodies to both B. burgdorferi and E. equi in sera from American residents. Thus, possible multiple infections with B. burgdorferi and granulocytic ehrlichiae should be taken into account when diagnosing a tick-borne infection in Europe.
In a preliminary study using PCR with HGE-specific oligonucleotide primers (13, 20) we found that 2 of 60 ticks collected near Munich were positive for granulocytic ehrlichiae, indicating a low prevalence of infected ticks compared with B. burgdorferi. While these PCR results support the serologic finding reported here, more data are needed to firmly establish the presence of the HGE agent in ticks and humans in southern Germany.
In conclusion, we have found evidence for the existence of HGE or closely related organisms in southern Germany in groups at high risk for exposure to the likely vector, I. ricinus. Physicians should be aware of the possible existence of this disease entity, particularly in cases when patients exposed to Ixodes ticks present with fevers and a rash or "atypical Lyme disease" (i.e., high fever, elevated liver enzymes, or sudden onset of symptoms) or do not respond to beta-lactam antibiotics or macrolides, which are not active against the HGE agent (15). Further studies, especially the cultivation of the pathogen from patients with clinically suggestive illnesses, are needed to clearly prove the clinical role of granulocytic ehrlichiae in causing disease in Europe. 
